Covid-19 vaccine: SII’s Covovax gets nod for emergency use in children aged 7 to 11 years
Image credit: morriscountynj.gov
The Covovax vaccine from Serum Institute was licenced by the Drugs Controller General of India (DCGI) on Tuesday for restricted emergency use in children aged 7 to 11 years, according to official sources.
The subject expert committee on Covid-19 of the CSDCO last week recommended granting Covovax an emergency use authorization for the age group of 7 to 11 years. The DCGI last week gave its approval.
On March 16, according to reliable sources, Prakash Kumar Singh, director of government and regulatory affairs at the Serum Institute of India (SII), submitted a request to the DCGI in this respect.
According to an official source, “the SEC last week considered the EUA application of SII and recommended granting emergency use authorization for Covovax for children aged 7 to 11 years.”
On December 28 and March 9, the DCGI approved the limited use of Covovax in emergency situations for adults, subject to specified restrictions, and for children aged 12 to 17.
The nation started immunising children between the ages of 12 and 14 on March 16. Healthcare workers received vaccinations as part of the initial phase of the nationwide vaccination campaign, which began on January 16 of last year. Front-line employees began receiving vaccinations on February 2 of last year. For individuals over the age of 60 and those with certain co-morbid illnesses who are 45 years of age or older, the COVID-19 vaccination’s second phase began on March 1 of last year.
India began vaccination programmes for all adults above 45 years old on April 1 of last year. The government subsequently made the decision to broaden its immunisation campaign by enabling everyone above the age of 18 to receive the viral illness vaccine starting on May 1 of last year.
Beginning on January 3, adolescents between the ages of 15 and 18 began receiving the second round of vaccinations.
Indian healthcare and frontline workers, as well as people 60 years of age and older with comorbidities, started receiving precautionary vaccination doses on January 10. Beginning on April 10, private vaccination clinics began administering the COVID-19 precaution dose to all adults over the age of 18.
About The Author
